ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 73 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,266 | -20.9% | 37,594 | -0.8% | 0.00% | – |
| Q2 2023 | $317,679 | +1223.7% | 37,897 | +616.5% | 0.00% | – |
| Q1 2022 | $24,000 | +20.0% | 5,289 | +6.2% | 0.00% | – |
| Q4 2021 | $20,000 | -55.6% | 4,982 | -2.9% | 0.00% | – |
| Q3 2021 | $45,000 | -22.4% | 5,132 | 0.0% | 0.00% | – |
| Q2 2021 | $58,000 | +480.0% | 5,132 | +31.5% | 0.00% | – |
| Q1 2020 | $10,000 | -56.5% | 3,904 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | +35.3% | 3,904 | +19.0% | 0.00% | – |
| Q3 2019 | $17,000 | -15.0% | 3,282 | 0.0% | 0.00% | – |
| Q2 2019 | $20,000 | -33.3% | 3,282 | 0.0% | 0.00% | – |
| Q1 2019 | $30,000 | +11.1% | 3,282 | 0.0% | 0.00% | – |
| Q4 2018 | $27,000 | -18.2% | 3,282 | +39.1% | 0.00% | – |
| Q3 2018 | $33,000 | +73.7% | 2,360 | 0.0% | 0.00% | – |
| Q2 2018 | $19,000 | – | 2,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
| Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
| JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
| Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
| WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
| Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
| Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
| Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
| FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
| TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |